Modern Treatment Cover Mandated by IRDAI

Medical technology has advanced dramatically over the past decade, with robotic surgical systems, proton beam therapy, immunotherapy, and gene-based treatments becoming increasingly available at Indian hospitals. Yet health insurance policies have historically been slow to recognise these treatments, often classifying them as "experimental" and denying claims. IRDAI has intervened directly, mandating that all health plans cover a specific list of modern, advanced treatments that meet clinical evidence standards.

The IRDAI Modern Treatment Mandate

IRDAI''s standardised exclusions circular and the 2020 product regulations introduced a list of modern treatments that health plans are prohibited from excluding. These treatments must be covered up to the applicable sum insured or a defined sub-limit, and cannot be categorically denied as experimental. The mandate applies to all retail health indemnity plans issued or renewed from these notification dates onwards.

The Covered Modern Treatments

The IRDAI-mandated list of modern treatments includes (among others):

• Robotic surgeries: Minimally invasive procedures using robotic surgical systems (e.g., Da Vinci robot-assisted prostatectomy, colorectal surgery)
• Oral chemotherapy: Cancer treatment taken in pill form that would previously only have been covered if administered intravenously in hospital
• Immunotherapy: Including monoclonal antibody treatments for cancer (e.g., pembrolizumab, trastuzumab)
• Stem cell therapy: For blood and bone marrow conditions (haematopoietic stem cell transplant)
• Balloon sinuplasty: A minimally invasive ENT procedure for chronic sinusitis
• Deep brain stimulation: For neurological conditions such as Parkinson''s disease
• Intra-vitreal injections: For age-related macular degeneration and diabetic retinopathy
• Uterine artery embolisation: For fibroids as an alternative to hysterectomy
• HIFU (High-Intensity Focused Ultrasound): For prostate conditions
• Bronchial thermoplasty: For severe asthma

Sub-Limits on Modern Treatments

While insurers cannot exclude these treatments entirely, they may apply specific sub-limits — capping reimbursement at, say, 50% of the sum insured or a fixed amount. Given that robotic surgery premiums at private hospitals can cost ₹5–₹15 lakh and immunotherapy regimens can exceed ₹20 lakh per year, sub-limits can still leave patients with significant out-of-pocket costs. Compare sub-limits carefully when selecting a plan.

Older Policies vs Newer Policies

Policies issued before IRDAI''s modern treatment mandate came into effect may still carry exclusions for some of these treatments, particularly if they have not been renewed under the new product regulations. At your next renewal, confirm with your insurer that modern treatments are covered under your updated policy terms.

Practical Claims Guidance

• Obtain a written recommendation from the treating specialist that the chosen modern treatment is medically necessary and clinically appropriate.
• Pre-authorise the treatment with your insurer before it is performed — for high-cost procedures like robotic surgery, advance approval avoids later disputes.
• Ask the insurer to confirm in writing the sub-limit applicable before the procedure.

Conclusion

Modern treatment cover ensures that your health insurance keeps pace with the actual treatment options available at leading Indian hospitals. As more conditions become treatable through advanced techniques, having a plan that explicitly covers these approaches is increasingly important. When comparing plans on TruePolicy, ask specifically about modern treatment sub-limits and exclusions — the advisors there can help you find coverage that genuinely matches contemporary medical practice.